FDA approved new indication for drug containing an active Cannabis ingredient to treat seizures in rare genetic disease
On Jul. 31, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Epidiolex (cannabidiol) [CBD]…
On Jul. 31, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Epidiolex (cannabidiol) [CBD]…
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
On Jul. 31, 2020, Yale researchers reported that differing immune system responses of patients with COVID-19 can help…
On Jul. 31, 2020, Pfizer and BioNTech announced an agreement with the Ministry of Health, Labour and Welfare…
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
On Jul. 30, 2020, Tyson Foods announced that it had launched a new, industry-leading monitoring program and expanding…
On Jul. 30, 2020, LabCorpï¾® launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
On Jul. 30, 2020, BD (Becton, Dickinson) announced a $24 million investment from the U.S. Department of Defense…
On Jul. 30, 2020, Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2,…
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang…
On Jul. 29, 2020, Veracyte and MAVIDx announced an agreement for MAVIDx to develop ultra-high throughput genomic testing…
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
On Jul. 29, 2020, Heat Biologics announced successful pre-clinical testing of the Company’s COVID-19 vaccine, which demonstrated in-vivo…
On Jul. 29, 2020, Quest Diagnostics announced that the FDA had granted emergency use authorization for a new…
On Jul. 29, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
On Jul. 28, 2020, the U.S. International Development Finance Corp. (DFC) announced that it had signed a letter…
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
On Jul. 28, 2020, StartX, a non-profit startup community of more than 1600 Stanford faculty and alumni founders,…
On Jul. 28, 2020, Reata Pharmaceuticals announced that researchers at NYU Grossman School of Medicine (NYU) initiated an…
On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…
On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
On Jul. 25, 2020, LabCorpï¾® announced it received an Emergency Use Authorization from the FDA permitting diagnostic testing…
On Jul. 23, 2020, kidney transplantation from deceased donors with HIV to people living with both HIV and…
On Jul. 23, 2020, the Centers for Disease Control and Prevention (CDC) released new science-based resources and tools…